Therapy News and Research

RSS

Novartis launches ‘24 Life Hacks in 24 hours’ showing commitment to help people with MS access guidance and advice

World MS Day was created by the Multiple Sclerosis International Foundation (MSIF) in 2009 to raise global awareness of MS...

28 May 2015

Amgen to present clinical data on multiple blood cancer treatments at EHA 2015

Amgen today announced that it will present data from multiple Kyprolis (carfilzomib) for Injection, BLINCYTO (blinatumomab), oprozomib and Nplate (romiplostim)‎ studies at the 20th Congress of the European Hematology Association taking place in Vienna, June 11 - 14, 2015.

28 May 2015

Earlier antiretroviral treatment benefits HIV-infected individuals

A major international randomized clinical trial has found that HIV-infected individuals have a considerably lower risk of developing AIDS or other serious illnesses if they start taking antiretroviral drugs sooner, when their CD4+ T-cell count--a key measure of immune system health--is higher, instead of waiting until the CD4+ cell count drops to lower levels. Together with data from previous studies showing that antiretroviral treatment reduced the risk of HIV transmission to uninfected sexual partners, these findings support offering treatment to everyone with HIV.

28 May 2015

Brigatinib drug shows promise against ALK+ non-small cell lung cancer in phase I/II clinical trial

Phase I/II clinical trial results reported at the American Society for Clinical Oncology (ASCO) Annual Meeting 2015 show promising results for investigational drug brigatinib against ALK+ non-small cell lung cancer (NSCLC), with 58 of 78 ALK+ patients responding to treatment, including 50 of 70 patients who had progressed after previous treatment with crizotinib, the first licensed ALK inhibitor.

28 May 2015

UM researcher receives grant to examine effects of CBT on racial/ethnic minority smokers

Numerous studies have shown that African Americans and Hispanics are less likely than Caucasians to quit smoking, even if they participate in cessation interventions.

28 May 2015

RegenScientific gets FDA approval for Renu Gel injectable implant

RegenScientific announced that it has received FDA-clearance for its Renu Gel injectable implant indicated for vocal fold injection augmentation and today the company commenced shipments of this new product to physicians and hospitals in the United States.

28 May 2015

Children's National Health System first in U.S. to treat osteoid osteoma using MR-HIFU method

Doctors from the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System are the first in the United States to treat osteoid osteoma, a benign but painful bone tumor that commonly occurs in children and young adults, using an experimental magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) method.

28 May 2015

FEV1/FVC lower limit of normal aids surgery risk stratification in COPD

Researchers say that using the lower limit of normal of the forced expiration volume in 1 second/forced vital capacity ratio improves risk stratification in patients with chronic obstructive pulmonary disease undergoing thoracic surgery.

27 May 2015

Aldosterone/renin ratio reliable diagnostic tool in infant primary hypoaldosteronism

The ratio of aldosterone to renin in plasma is a reliable indicator of primary hypoaldosteronism in newborns and infants, say researchers.

27 May 2015

Individualised GH dosing provides cost-effective catch-up growth in ISS

Treating children with idiopathic short stature with an individualised, formula-based dose of recombinant human growth hormone induces equivalent catch-up growth to that achieved with a standard dose, show findings from a randomised trial.

27 May 2015

GOLD 2007 and 2011 fail to accurately predict mortality risk

Neither the 2007 nor the 2011 Global Initiative for Chronic Obstructive Lung Disease classification systems have sufficient prognostic accuracy to predict mortality, a pooled analysis of individual patient data shows.

27 May 2015

Strand Life Sciences to launch expanded StrandAdvantage pan-cancer genomic profiling service at ASCO 2015

Strand Life Sciences, a global genomic profiling company that uses next generation sequencing technology to empower cancer care, today announced it will introduce its expanded StrandAdvantage pan-cancer genomic profiling service later this month at the 2015 American Society of Clinical Oncology Annual Meeting in Chicago.

27 May 2015

Six research teams awarded grant to accelerate discovery of new drugs for brain, nervous system disorders

CQDM, Brain Canada and the Ontario Brain Institute award close to $8.5M to six (6) multi-disciplinary and multi-provincial research teams across Canada to address unmet needs in neuroscience within their Focus on Brain strategic initiative. To this amount, $1.5M is added from the various research entities involved as in-kind contributions.

27 May 2015

Scorpion venom could kill cancer cells

When the toxin invades channels in the cells with this disease produces cellular damage until killing them.

27 May 2015

Carbon monoxide may actually protect the brain from damage after subarachnoid hemorrhage

Carbon monoxide is known by many as a poisonous gas that causes brain injury and other neurological symptoms, including memory loss and confusion. But a new study led by investigators at Beth Israel Deaconess Medical Center suggests the opposite may be true: When administered in small, carefully controlled amounts, carbon monoxide may actually protect the brain from damage following subarachnoid hemorrhage, a devastating stroke that results from bleeding in the brain.

27 May 2015

UC San Diego Health System designated as Center of Excellence for Huntington's disease

The Huntington's Disease Clinical Research Center at UC San Diego Health System has been designated a Center of Excellence by the Huntington's Disease Society of America. UC San Diego was one of only 29 centers nationwide to receive this prestigious designation, which recognizes centers for their elite multidisciplinary approach to Huntington's disease care and research.

27 May 2015

Helsinn Group announces European approval of ALOXI (palonosetron HCl) injection for paediatric use

Helsinn Group, the Swiss Group focused on building quality cancer care, today announces that the European Commission has endorsed the Committee for Medicinal Products for Human Use's Opinion recommending the approval of ALOXI (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy and the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy, in paediatric patients one month of age and older.

27 May 2015

AbbVie announces new results from Phase 3 GIFT-I study in GT1b HCV infected Japanese patients

AbbVie presented new results from the Phase 3 GIFT-I study of its investigational, all-oral, interferon (IFN)- and ribavirin (RBV)-free, two direct-acting antiviral treatment with ombitasvir/paritaprevir/ritonavir at the Annual Meeting of the Japan Society of Hepatology in Kumamoto, Japan.

27 May 2015

New stem-cell based therapy provides pain relief, reduces severity of RDEB in children

Promising results from a trial of a new stem-cell based therapy for a rare and debilitating skin condition have been published in the Journal of Investigative Dermatology. The therapy, involving infusions of stem cells, was found to provide pain relief and to reduce the severity of this skin condition for which no cure currently exists.

27 May 2015

New investments may enable two Canadian organizations to improve life for people with hearing loss

New investments from public and private sources in Canada and the USA, including Grand Challenges Canada and Google.org, will enable two Canadian organizations to contribute to a better life for people with hearing loss in developing countries.

27 May 2015

Therapy News and Research

Novartis launches ‘24 Life Hacks in 24 hours’ showing commitment to help people with MS access guidance and advice

Amgen to present clinical data on multiple blood cancer treatments at EHA 2015

Earlier antiretroviral treatment benefits HIV-infected individuals

Brigatinib drug shows promise against ALK+ non-small cell lung cancer in phase I/II clinical trial

UM researcher receives grant to examine effects of CBT on racial/ethnic minority smokers

RegenScientific gets FDA approval for Renu Gel injectable implant

Children's National Health System first in U.S. to treat osteoid osteoma using MR-HIFU method

FEV1/FVC lower limit of normal aids surgery risk stratification in COPD

Aldosterone/renin ratio reliable diagnostic tool in infant primary hypoaldosteronism

Individualised GH dosing provides cost-effective catch-up growth in ISS

GOLD 2007 and 2011 fail to accurately predict mortality risk

Strand Life Sciences to launch expanded StrandAdvantage pan-cancer genomic profiling service at ASCO 2015

Six research teams awarded grant to accelerate discovery of new drugs for brain, nervous system disorders

Scorpion venom could kill cancer cells

Carbon monoxide may actually protect the brain from damage after subarachnoid hemorrhage

UC San Diego Health System designated as Center of Excellence for Huntington's disease

Helsinn Group announces European approval of ALOXI (palonosetron HCl) injection for paediatric use

AbbVie announces new results from Phase 3 GIFT-I study in GT1b HCV infected Japanese patients

New stem-cell based therapy provides pain relief, reduces severity of RDEB in children

New investments may enable two Canadian organizations to improve life for people with hearing loss

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News